Lack of evidence in malignant pleural mesothelioma surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 3, 2011, Pages 347-348

  Rena, Ottavio ^a   Casadio, Caterina ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Malignant pleural mesothelioma; Survey

Indexed keywords

CANCER ADJUVANT THERAPY; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; EDITORIAL; HUMAN; LIFESPAN; LUNG RESECTION; MEDICAL EDUCATION; PLEURA MESOTHELIOMA; PLEURECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; SURGEON; SURGICAL TRAINING;

ATTITUDE OF HEALTH PERSONNEL; EUROPE; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MESOTHELIOMA; PATIENT SELECTION; PLEURAL NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RISK ASSESSMENT; SOCIETIES, MEDICAL; THORACIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 79952331854     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.258301     Document Type: Editorial

References (8)

1. Treasure T, Internullo E, Fiorentino F, Van Remdonck D, Van Schil P, DeCamp M, Wood D, Utley M. A survey of opinions and beliefs concerning surgery for malignant pleural mesothelioma amongst 802 members of the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Thoracic Surgeons (ESTS) and the Society of Thoracic Surgeons (STS). Interact CardioVasc Thorac Surg 2011;12:341- 346.
2. Pelucchi C, Malvezzi M, La Vecchia C, Levi F, Decarli A, Negri E. The mesothelioma epidemic in Western Europe: an update. Br J Cancer 2004;90:1022-1024.
3. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strass GM, Corson JM, DeCamp MM Jr, Swanson SJ, Bueno R, Lukanich JM, Baldini EH, Mentzer SJ. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-65.
4. Trousse DS, Avaro JP, D'Journo XB, Doddoli C, Astoul P, Giudicelli R, Fuentes PA, Thomas PA. Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies. Eur J Cardiothorac Surg 2009;36:759-763.
5. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, Bains MS, Rusch VW. Extrapleural pneumonectomy versus pleurectomyydecor-tication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008;135:620-626.
6. Nakas A, Trousse DS, Martin-Ucar AE, Waller DA. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy. Eur J Cardiothorac Surg 2008; 34:886-891.
7. Treasure T, Waller D, Tan C, Entwisle J, O'Brien M, O'Byrne K, Thomas G, Snee M, Spicer J, Landau D, Lang-Lazdunski L, Bliss J, Peckitt C, Rogers S, Marriage E, Coombes G, Webster-Smith M, Peto J. The MARS trialists. The Mesothelioma and Radical Surgery randomised controlled trial: the MARS feasibility study. J Thorac Oncol 2009;4:1254-1258.
8. Van Schi PE, Baas P, Gaafar R, Maat AP, van de Pol M, Hasan B, Klomp HM, Abdelrahman AM, Welch J, Van Meerbeeck J on behalf of the EORTC Lung Cancer Group. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J 2010;36:1362-1369.